Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | – | – |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |